Published in Genes Dev on February 01, 1992
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol (1994) 3.48
Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J (1999) 3.35
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol (1994) 3.07
Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol (1994) 2.54
Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1998) 1.94
Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol Mol Biol Rev (2000) 1.86
mRNA transport in yeast: time to reinvestigate the functions of the nucleolus. Mol Biol Cell (1995) 1.83
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1-related mRNAs. Proc Natl Acad Sci U S A (1997) 1.26
The choice of alternative 5' splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc Natl Acad Sci U S A (1995) 1.23
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis. J Virol (2002) 1.04
A suboptimal 5' splice site is a cis-acting determinant of nuclear export of polyomavirus late mRNAs. Mol Cell Biol (1996) 1.00
Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. J Virol (2000) 0.97
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate. J Virol (2008) 0.85
Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export. Viruses (2013) 0.82
Deletion derivatives of the MuDR regulatory transposon of maize encode antisense transcripts but are not dominant-negative regulators of mutator activities. Plant Cell (2003) 0.81
Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. Am J Physiol Lung Cell Mol Physiol (2009) 0.80
Implication of a cis-acting element in the cytoplasmic accumulation of unspliced Borna disease virus RNAs. J Virol (1997) 0.79
Identification of a casein kinase II phosphorylation domain in NS1 protein of H5N1 influenza virus. Bioinformation (2007) 0.78
New approach for inhibiting Rev function and HIV-1 production using the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1996) 0.77
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell (1997) 6.34
Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev (1997) 5.66
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell (1998) 5.60
Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A (1981) 5.10
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J (2001) 4.61
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell (1983) 3.93
Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science (1998) 3.85
Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J Virol (1988) 3.49
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol (1994) 3.48
Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J Virol (1977) 3.38
Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J (1999) 3.35
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev (1999) 3.14
Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol (1998) 3.11
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end. Proc Natl Acad Sci U S A (1986) 3.09
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol (1981) 2.68
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev (1994) 2.64
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol (1994) 2.54
Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol (1983) 2.53
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41
Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology (1973) 2.40
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures. J Virol (1976) 2.22
Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol (1987) 2.21
The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol (1987) 2.20
The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol (1998) 2.19
Influenza viral RNPs newly synthesized during the latent period of viral growth in MDCK cells. Virology (1971) 2.19
Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts. J Virol (1975) 2.17
A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol (1997) 2.16
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U S A (1997) 2.15
The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA (1995) 2.12
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia (2005) 2.09
Tunable (deltapi, deltapi)-type antiferromagnetic order in alpha-Fe(Te,Se) superconductors. Phys Rev Lett (2009) 2.03
Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med (1998) 2.02
Influenza viral messenger RNA. Virology (1974) 1.99
Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem (2001) 1.98
Segments of influenza virus complementary RNA synthesized in vitro. J Virol (1978) 1.97
Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol Cell Biol (1984) 1.97
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1998) 1.94
Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells. Virology (1972) 1.92
Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation (1998) 1.90
Neutron-diffraction measurements of magnetic order and a structural transition in the parent BaFe2As2 compound of FeAs-based high-temperature superconductors. Phys Rev Lett (2008) 1.86
Selective neuronal targeting in prion disease. Neuron (1997) 1.82
Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol (1988) 1.77
Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer (2007) 1.75
Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res (1999) 1.75
The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology (1995) 1.74
Priming and inhibitory activities of RNAs for the influenza viral transcriptase do not require base pairing with the virion template RNA. Proc Natl Acad Sci U S A (1980) 1.72
Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers. Nature (1998) 1.61
Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res (1997) 1.61
Ligand-induced heme ruffling and bent no geometry in ultra-high-resolution structures of nitrophorin 4. Biochemistry (2001) 1.61
Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol (1986) 1.61
The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology (1996) 1.60
Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus. J Virol (1986) 1.59
The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons. Neuron (1999) 1.59
Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell (1984) 1.57
Identification of the RNA region transferred from a representative primer, beta-globin mRNA, to influenza mRNA during in vitro transcription. Nucleic Acids Res (1980) 1.55
Nuclear accumulation of influenza viral RNA transcripts and the effects of cycloheximide, actinomycin D, and alpha-amanitin. J Virol (1979) 1.54
Mediation of Sonic hedgehog-induced expression of COUP-TFII by a protein phosphatase. Science (1997) 1.54
Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest (1996) 1.52
The segments of influenza viral mRNA. J Virol (1977) 1.51
Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res (1999) 1.48
Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol (2001) 1.46
Synthesis of the templates for influenza virion RNA replication in vitro. Proc Natl Acad Sci U S A (1984) 1.45
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design. Eur Respir J (2006) 1.45
From (pi,0) magnetic order to superconductivity with (pi,pi) magnetic resonance in Fe(1.02)Te(1-x)Se(x). Nat Mater (2010) 1.45
Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol (2000) 1.44
Overlapping genes in a yeast double-stranded RNA virus. J Virol (1989) 1.44
Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo. Nucleic Acids Res (1981) 1.43
Two of the three influenza viral polymerase proteins expressed by using baculovirus vectors form a complex in insect cells. J Virol (1987) 1.41
Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res (1998) 1.39
Studies on the intranuclear localization of influenza virus-specific proteins. Virology (1975) 1.38
Use of specific radioactive probes to study transcription and replication of the influenza virus genome. J Virol (1977) 1.36
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol (1999) 1.35
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol (2000) 1.35
Potential metabolite markers of schizophrenia. Mol Psychiatry (2011) 1.35
Spin dynamics of the spin-1/2 kagome lattice antiferromagnet ZnCu3(OH)6Cl2. Phys Rev Lett (2007) 1.34
Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat Cell Biol (2001) 1.34
Selective nuclear export of viral mRNAs in influenza-virus-infected cells. Trends Microbiol (2000) 1.33
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): expression during mouse embryogenesis. J Steroid Biochem Mol Biol (1995) 1.32
PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol (1999) 1.31
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J (2007) 1.30